Cost-effectiveness analysis of newborn screening for sickle-cell disease in Spain

  1. Castilla-Rodríguez, I.
  2. Cela, E.
  3. Vallejo-Torres, L.
  4. Valcárcel-Nazco, C.
  5. Dulín, E.
  6. Espada, M.
  7. Rausell, D.
  8. Mar, J.
  9. Serrano-Aguilar, P.
Journal:
Expert Opinion on Orphan Drugs

ISSN: 2167-8707

Year of publication: 2016

Volume: 4

Issue: 6

Pages: 567-575

Type: Article

DOI: 10.1080/21678707.2016.1179572 GOOGLE SCHOLAR